PE20010030A1 - Compuesto heteroaromatico biciclico - Google Patents

Compuesto heteroaromatico biciclico

Info

Publication number
PE20010030A1
PE20010030A1 PE2000000312A PE0003122000A PE20010030A1 PE 20010030 A1 PE20010030 A1 PE 20010030A1 PE 2000000312 A PE2000000312 A PE 2000000312A PE 0003122000 A PE0003122000 A PE 0003122000A PE 20010030 A1 PE20010030 A1 PE 20010030A1
Authority
PE
Peru
Prior art keywords
alkyl
cycloalkyl
heteroaromatic
compound
alkinyl
Prior art date
Application number
PE2000000312A
Other languages
English (en)
Spanish (es)
Inventor
Gerritdina Geziena Gerritsma
Straten Nicole Corine Renee Van
Anton Egbert Peter Adang
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PE20010030A1 publication Critical patent/PE20010030A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
PE2000000312A 1999-04-08 2000-04-06 Compuesto heteroaromatico biciclico PE20010030A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99201152 1999-04-08

Publications (1)

Publication Number Publication Date
PE20010030A1 true PE20010030A1 (es) 2001-01-27

Family

ID=8240094

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000312A PE20010030A1 (es) 1999-04-08 2000-04-06 Compuesto heteroaromatico biciclico

Country Status (30)

Country Link
US (2) US6569863B1 (enExample)
EP (1) EP1171443B1 (enExample)
JP (1) JP4854856B2 (enExample)
KR (1) KR100691546B1 (enExample)
CN (1) CN1177848C (enExample)
AR (1) AR028474A1 (enExample)
AT (1) ATE299507T1 (enExample)
AU (1) AU772258B2 (enExample)
BR (1) BRPI0009558B1 (enExample)
CA (1) CA2368834C (enExample)
CO (1) CO5160348A1 (enExample)
CZ (1) CZ300832B6 (enExample)
DE (1) DE60021262T2 (enExample)
DK (1) DK1171443T3 (enExample)
ES (1) ES2245304T3 (enExample)
HK (1) HK1041266B (enExample)
HU (1) HU229002B1 (enExample)
ID (1) ID30502A (enExample)
IL (2) IL145483A0 (enExample)
MX (1) MXPA01010144A (enExample)
NO (1) NO328826B1 (enExample)
NZ (1) NZ514445A (enExample)
PE (1) PE20010030A1 (enExample)
PL (1) PL219316B1 (enExample)
PT (1) PT1171443E (enExample)
RU (1) RU2248979C2 (enExample)
TR (1) TR200102839T2 (enExample)
TW (1) TW564247B (enExample)
WO (1) WO2000061586A1 (enExample)
ZA (1) ZA200107917B (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4977940B2 (ja) 2000-09-22 2012-07-18 エム・エス・ディー・オス・ベー・フェー 二環式ヘテロ芳香族化合物
GB0100622D0 (en) 2001-01-10 2001-02-21 Vernalis Res Ltd Chemical compounds V111
DE10108481A1 (de) 2001-02-22 2002-10-24 Bayer Ag Pyridylpyrimidine
EP1427734B1 (en) * 2001-09-04 2005-11-09 Akzo Nobel N.V. GLYCINE-SUBSTITUTED THIENO[2,3-d]PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY
TWI228508B (en) * 2001-09-04 2005-03-01 Akzo Nobel Nv Thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity
UY27834A1 (es) 2002-06-06 2003-12-31 Boehringer Ingelheim Pharma Compuestos de amidas de acido 3-amino-tieno(2,3-b) piiridino-2-carboxilico sustituido y procedimientos para prepararlos y sus usos.
US6974870B2 (en) 2002-06-06 2005-12-13 Boehringer Ingelheim Phamaceuticals, Inc. Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
WO2004092173A2 (en) 2003-04-09 2004-10-28 Biogen Idec Ma Inc. A2a adenosine receptor antagonists
US7674791B2 (en) 2003-04-09 2010-03-09 Biogen Idec Ma Inc. Triazolopyrazines and methods of making and using the same
US7285550B2 (en) 2003-04-09 2007-10-23 Biogen Idec Ma Inc. Triazolotriazines and pyrazolotriazines and methods of making and using the same
JPWO2005019225A1 (ja) * 2003-08-21 2007-11-01 杏林製薬株式会社 Ｎｋ１受容体拮抗作用を有する化合物の製造方法及びその製造中間体
US7550485B2 (en) * 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
WO2005039506A2 (en) * 2003-10-24 2005-05-06 Exelixis, Inc. P70s6 kinase modulators and method of use
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
NZ553329A (en) * 2004-07-22 2010-09-30 Ptc Therapeutics Inc Thienopyridines for treating hepatitis C
CA2630920A1 (en) * 2005-11-22 2007-05-31 University Of South Florida Inhibition of cell proliferation
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
AU2007254165A1 (en) * 2006-05-17 2007-11-29 Forschungsverbund Berlin E.V. Pyrimidine low molecular weight ligands for modulating hormone receptors
EP2029608A1 (en) 2006-06-06 2009-03-04 Boehringer Ingelheim International GmbH Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxamide compounds, their preparation and use
RU2444524C2 (ru) * 2006-08-21 2012-03-10 Дженентек, Инк. Азабензотиофенильные соединения и способы применения
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
KR20100065191A (ko) 2007-09-14 2010-06-15 오르토-맥닐-얀센 파마슈티칼스 인코포레이티드 １,３-이치환된 ４-(아릴-ｘ-페닐)-１ｈ-피리딘-２-온
MX2010002536A (es) 2007-09-14 2010-08-10 Ortho Mcneil Janssen Pharm 4-fenil-3,4,5,6-tetrahidro-2h, 1'h-[1,4]bipiridinil-2'-onas 1',3'-disubstituidas.
EP2205565B1 (en) * 2007-09-14 2013-04-17 Janssen Pharmaceuticals, Inc. 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones
CN103497201A (zh) * 2007-10-18 2014-01-08 贝林格尔.英格海姆国际有限公司 二氢噻吩并[3,2-d]嘧啶的制备中使用的中间体及其制备
EP2220083B1 (en) 2007-11-14 2017-07-19 Janssen Pharmaceuticals, Inc. Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MX2011002042A (es) 2008-09-02 2011-06-20 Ortho Mcneil Janssen Pharm Derivados de 3-azabiciclo[3.1.o]hexilo como moduladores de los receptores del glutamato metabotropico.
AU2009304293B2 (en) 2008-10-16 2012-04-26 Addex Pharma S.A. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
CN102232074B (zh) 2008-11-28 2014-12-03 奥梅-杨森制药有限公司 作为代谢性谷氨酸盐受体调节剂的吲哚和苯并噁嗪衍生物
EA020672B1 (ru) 2009-05-12 2014-12-30 Янссен Фармасьютикалс, Инк. Производные 1,2,4-триазоло[4,3-a]пиридина и их применение для лечения или предупреждения неврологических и психиатрических расстройств
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
SG176018A1 (en) 2009-05-12 2011-12-29 Janssen Pharmaceuticals Inc 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CA2815002C (en) 2010-11-08 2019-10-22 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
ES2552455T3 (es) 2010-11-08 2015-11-30 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
US9012448B2 (en) 2010-11-08 2015-04-21 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
RU2014103185A (ru) 2011-07-18 2015-08-27 Артс Байолоджикс А/С Биологически активное соединение на основе лютеинизирующего гормона (lh) с пролонгированным действием
MX355088B (es) 2011-11-23 2018-04-04 Cancer Research Tech Ltd Inhibidores de tienopirimidina de proteina cinasa c atipica.
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
UA121965C2 (uk) 2014-01-21 2020-08-25 Янссен Фармацевтика Нв Комбінації, які містять позитивні алостеричні модулятори або ортостеричні агоністи метаботропного глутаматергічного рецептора 2 підтипу, та їх застосування
KR102502485B1 (ko) 2014-01-21 2023-02-21 얀센 파마슈티카 엔.브이. 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
CN107602585A (zh) * 2017-10-23 2018-01-19 遵义医学院 噻吩并吡啶双杂环化合物的制备工艺
BR102019022529A2 (pt) * 2019-10-25 2021-05-04 Anhanguera Educacional Ltda. Processo para obtenção de composições farmacêuticas antitumorais através de butadienos push-pull, compostos e seus usos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993013664A2 (en) * 1992-01-11 1993-07-22 Schering Agrochemicals Limited Biheterocyclic fungicidal compounds
TW449600B (en) 1994-04-19 2001-08-11 Takeda Chemical Industries Ltd Condensed-ring thiophene derivatives, their production and use
JP3854648B2 (ja) * 1994-04-19 2006-12-06 武田薬品工業株式会社 縮合チオフェン誘導体、その製造法及び用途
HUT77348A (hu) * 1994-11-08 1998-03-30 Takeda Chemical Industries, Ltd. Tienopiridin- és tienopirimidinszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
EP0862573A1 (en) * 1995-10-19 1998-09-09 Takeda Chemical Industries, Ltd. Thienopyridine derivatives as gonadotropin releasing hormone antagonists
JPH09169767A (ja) * 1995-10-19 1997-06-30 Takeda Chem Ind Ltd 複素環化合物、その製造法および用途
JPH09169766A (ja) * 1995-10-19 1997-06-30 Takeda Chem Ind Ltd チエノピリジン誘導体，その製造法および用途
EP0900222A1 (en) * 1996-04-26 1999-03-10 Takeda Chemical Industries, Ltd. Thienopyridine derivatives, their production and use

Also Published As

Publication number Publication date
PL350964A1 (en) 2003-02-24
AU3816600A (en) 2000-11-14
CN1349535A (zh) 2002-05-15
US20030212081A1 (en) 2003-11-13
TW564247B (en) 2003-12-01
HUP0200653A3 (en) 2004-07-28
CO5160348A1 (es) 2002-05-30
NO20014824D0 (no) 2001-10-04
ID30502A (id) 2001-12-13
HUP0200653A2 (en) 2002-06-29
JP2002541259A (ja) 2002-12-03
RU2248979C2 (ru) 2005-03-27
CZ300832B6 (cs) 2009-08-19
WO2000061586A1 (en) 2000-10-19
BR0009558A (pt) 2002-02-19
AR028474A1 (es) 2003-05-14
AU772258B2 (en) 2004-04-22
IL145483A0 (en) 2002-06-30
NO328826B1 (no) 2010-05-25
JP4854856B2 (ja) 2012-01-18
DK1171443T3 (da) 2005-11-07
KR20010103801A (ko) 2001-11-23
IL145483A (en) 2007-06-03
DE60021262T2 (de) 2006-01-05
CA2368834C (en) 2009-11-03
CN1177848C (zh) 2004-12-01
KR100691546B1 (ko) 2007-03-12
NO20014824L (no) 2001-10-04
CZ20013605A3 (cs) 2002-03-13
US6569863B1 (en) 2003-05-27
TR200102839T2 (tr) 2002-04-22
US6841553B2 (en) 2005-01-11
HK1041266A1 (en) 2002-07-05
NZ514445A (en) 2003-07-25
CA2368834A1 (en) 2000-10-19
BRPI0009558B1 (pt) 2016-10-25
ES2245304T3 (es) 2006-01-01
ZA200107917B (en) 2003-09-23
HK1041266B (en) 2005-09-16
EP1171443B1 (en) 2005-07-13
PL219316B1 (pl) 2015-04-30
ATE299507T1 (de) 2005-07-15
HU229002B1 (en) 2013-07-29
MXPA01010144A (es) 2002-04-24
PT1171443E (pt) 2005-11-30
EP1171443A1 (en) 2002-01-16
DE60021262D1 (de) 2005-08-18

Similar Documents

Publication Publication Date Title
PE20010030A1 (es) Compuesto heteroaromatico biciclico
PE20050131A1 (es) Derivados de benzoimidazol como agentes antiproliferativos
PE20050087A1 (es) Derivados de 2-oxodihidropiridina n-sustituidos
PE20130647A1 (es) Indoles
PE20071171A1 (es) Derivados de acido nicotinico como moduladores de receptores de glutamato metabotropicos
PE20090601A1 (es) Derivados de piridin-il-oxi-piridinas como inhibidores de alk5
PE20091236A1 (es) Derivados de pirimidina como immunomoduladores de tlr7
PE20080608A1 (es) Compuestos quimicos
PE20060664A1 (es) Amidas biciclicas como inhibidores de cinasa
PE20011305A1 (es) Agentes diazabiciclicos activos en el snc
PE20011035A1 (es) Ureas ciclicas sustituidas como antagonistas de los receptores de neuroquinina
PE20011030A1 (es) Combinaciones farmaceuticas que comprenden tegaserod y omeprazol
GT200200197A (es) Derivados de quinolina
DE69840296D1 (de) Phenylethylenamin-derivate
PE20040772A1 (es) Composicion y actividad antiviral de derivados de piperazina azaindoloxoaceticos
CA2304204A1 (en) Quinoline-containing .alpha.-ketoamide cysteine and serine protease inhibitors
PE20110117A1 (es) Derivados de 3,5-piridina como inhibidores de renina
PE20060625A1 (es) Derivados de benzazepina como antagonistas y/o agonistas del receptor h3 de histamina
PE20060623A1 (es) Compuestos de sulfonamida como potenciadores del receptor de glutamato
CA2461060A1 (en) Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof
PE20090955A1 (es) Compuestos de tetrahidroquinolina como antagonistas del receptor de tsh
PE20040928A1 (es) Derivados de tetrahidroquinolinas como moduladores del receptor fsh
GB1177840A (en) 2-Thiopyrimidine Nucleosides
PE20120766A1 (es) Derivados de quinoxalina como inhibidores de tumores
PE20020537A1 (es) Compuestos heteroaromaticos biciclicos como agonistas de la hormona luteinizante (lh)

Legal Events

Date Code Title Description
FC Refusal